← FDA Drug Approvals (Drugs@FDA)
OXYBUTYNIN CHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL RX · Approved 2018-05-31
Drug application
- FDA Application #
ANDA207329- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OXYBUTYNIN CHLORIDE
- Generic name
- Oxybutynin Chloride
- Active ingredients
- OXYBUTYNIN CHLORIDE
- Dosage form
- GEL
- Route
- TRANSDERMAL
- Marketing status
- Discontinued
- Sponsor
- CHARTWELL RX
- First approval
- 2018-05-31
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown